Utilities and disutilities for attributes of injectable treatments for type 2 diabetes
Kristina S. Boye; Louis S. Matza; Kimberly N. Walter; Kate Van Brunt; Andrew C. Palsgrove...
Year of publication: |
2011
|
---|---|
Authors: | Boye, Kristina S. ; Matza, Louis S. ; Walter, Kimberly N. ; Van Brunt, Kate ; Palsgrove, Andrew C. |
Published in: |
The European journal of health economics : HEPAC ; health economics in prevention and care. - Berlin : Springer, ISSN 1618-7598, ZDB-ID 2045253-6. - Vol. 12.2011, 3, p. 219-230
|
Saved in:
Saved in favorites
Similar items by person
-
Health state utilities for skeletal-related events secondary to bone metastases
Matza, Louis S., (2014)
-
Matza, Louis S., (2016)
-
Health state utilities associated with treatment for transfusion-dependent β-thalassemia
Matza, Louis S., (2020)
- More ...